Helixgate https://validator.w3.org/feed/docs/rss2.html 2026 report on biotech’s economic impact portrays a vast ecosystem IP: American as apple pie and essential for biotech BIO supports FDA’s new Fit-for-Purpose Rare Disease Framework Initiative Flagship blends three biotech startups to form Etcelera CDC report details impact of AMR pathogens HHS to allow compounders to make 6 unapproved peptides Genmab soars to record highs after cancer drug succeeds in key trial Research report: The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies Stigmatizing language found in over half of primary care patient records LncRNA SBF2-AS1 Worsens Heart Injury After Attack via miR-149-5p/PHLPP2 Axis Biopharma cuts at manufacturing plants expected to affect 4,000+ HHS clears compounding pharmacies to manufacture 6 unapproved peptides Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms What a cancer survivor sees that AI could miss in trial design Microbial Dark Matter Could Revive Antibiotics Decentralization, AI, and Gene Editing Are Opportunities for CGT Contractors Crossing the Digital Validation Chasm How the Heart Stays Strong with MCT1-Dependent Mitochondrial Lactate Import Three-Photon Microscopy Reveals Neural Activity Deep in the Mouse Brain Hamburg Hosts 2026 European Gene Therapy Conference Building the Future of AAV Gene Therapy Brain Quality Control Selectively Eliminates Neurons with Abnormal Variants in Development Stability, speed and strategy: Inside Australia’s early‑stage edge Ono cans 2 endocannabinoid drug studies after quintuple Phase 2 failure BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat Dren Bio lands $350M to push rare blood cancer therapy toward market Quality and Regulatory Predictability: Shaping USP Standards – 12/11/2025 Search for Regulatory References | Drugs FDA Drug Info Rounds Video Frequently Requested or Proactively Posted Compliance Records Submit an eCTD v4.0 or Standardized Data Sample to the FDA Project Orbis Webinar for Stakeholder Engagement on the New Final Guideline on General Principles for Model-Informed Drug Development (ICH M15) – 10/29/2026 Drugs@FDA Data Files Newly Added Guidance Documents What’s New Related to Drugs LENZ cuts 75% of staff as third quarter earnings disappoint eCTD Submission Standards for eCTD v4.0 and Regional M1 STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more STAT+: HHS moves to allow compounding of some unapproved peptides Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout AbbVie bids to join the BCMA crowd with etentamig GSK shares come under pressure from weaker vaccine sales Artiva to quit autoimmune cell therapy work, cut staff after patient deaths Ferring to acquire next-gen IVF startup Gameto for up to $1.4B FDA unveils guidance for ‘plug and play’ gene therapies Oruka raises efficacy expectations for long-acting IL-23 inhibitors PACE panels tackle challenges to access and barriers to coverage Behind the scenes of 3 Big Pharma layoffs Home